차세대 시퀀싱(NGS) 자동화 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 시퀀싱 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global NGS Automation Market size was valued at USD 0.45 Million in 2024 and is poised to grow from USD 0.51 Million in 2025 to USD 1.4 Million by 2033, growing at a CAGR of 13.4% during the forecast period (2026-2033).

The global NGS automation market is experiencing significant growth driven by advancements in high-throughput sequencing technologies. These innovations facilitate quicker and more cost-effective generation of DNA and RNA compared to traditional methods, revolutionizing genomics and molecular biology research. NGS automation workstations enhance library preparation through automated liquid handling, ensuring consistent, reliable, and reproducible data quality while reducing contamination risks. This automation minimizes manual intervention, increasing productivity and lowering error rates in the NGS workflow. The rising demand for automation is further propelled by its applications in drug development and a diverse range of offerings from major industry players. However, challenges such as high product costs and recalls may hinder market expansion. Overall, the landscape presents a dynamic and evolving opportunity for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global NGS Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global NGS Automation Market Segments Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global NGS Automation Market

The Global NGS Automation market is driven by several key factors, including the growing demand for streamlined automation within next-generation sequencing workflows, alongside the increasing incidence of cancer. Additionally, rising investments in research and development, in conjunction with escalating healthcare expenditures, are further propelling market growth. The broadening applications of next-generation sequencing technology, coupled with a surge in collaborations among companies aimed at developing innovative library preparation methods, are also contributing to the market's significant expansion. Together, these elements are set to shape the future landscape of the NGS automation sector.

Restraints in the Global NGS Automation Market

The Global NGS Automation market faces notable challenges that may impede its growth, primarily stemming from the elevated costs associated with automation workstations. Additionally, regulatory hurdles and the lack of standardization in diagnostic testing present significant obstacles to industry expansion. Furthermore, the necessity for a workforce equipped with specialized skills to effectively operate automation software adds another layer of difficulty. These factors collectively contribute to a complex environment that may restrain the market's potential for growth, as stakeholders navigate the balance between investing in automation and addressing regulatory and operational requirements.

Market Trends of the Global NGS Automation Market

The Global NGS Automation market is experiencing significant growth due to the increasing adoption of automation technologies that enhance the efficiency and reliability of next-generation sequencing (NGS) workflows. By streamlining library preparation processes, automation not only improves data quality and yield consistency but also boosts productivity while simultaneously reducing operational costs. Furthermore, the diminished manual handling of samples and reagents minimizes contamination risks, fostering a more reliable research environment. As researchers and laboratories seek to improve workflow efficiency and accuracy, the demand for advanced NGS automation solutions is set to escalate, shaping a promising market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Workstation/Robotic Platform
• Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Clinical Diagnostics
• Oncology
• Infectious Diseases
• Reproductive Health
• Other Clinical Diagnostics
• Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2026-2033)

• Market Overview
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Genome Sequencing
• Others

Global NGS Automation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Others End Users

Global NGS Automation Market Size & CAGR (2026-2033)

• North America (Product, Application, Sequencing Type, End User)
  • US
  • Canada
• Europe (Product, Application, Sequencing Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Sequencing Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Sequencing Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Sequencing Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hudson Robotics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeywell International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (Laboratory Corporation of America Holdings) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations